Pharmacotherapy for prevention of post-traumatic stress disorder
Date
2006
Authors
Ipser J.C.
Seedat S.
Stein D.J.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: 1) To provide an estimate of the efficacy of medication in preventing the development of post-traumatic stress disorder following exposure to a traumatic event. The efficacy of medication in reducing symptom severity for those individuals who subsequently develop PTSD will also be considered. 2) To determine whether particular classes of medication are more effective and/or acceptable than others in the prevention of PTSD. 3) To assess whether depression is a predictor of treatment response in the prevention of PTSD. Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Description
Keywords
alprazolam, amitriptyline, benzodiazepine, brofaromine, bromazepam, buspirone, citalopram, clomipramine, clonazepam, desipramine, escitalopram, fluoxetine, fluvoxamine, haloperidol, imipramine, inositol, lithium, moclobemide, monoamine oxidase inhibitor, neuroleptic agent, paroxetine, phenelzine, pindolol, prazosin, quetiapine, risperidone, serotonin uptake inhibitor, sertraline, tricyclic antidepressant agent, venlafaxine, behavior therapy, clinical trial, data analysis, depression, drug efficacy, human, information processing, methodology, posttraumatic stress disorder, psychotherapy, review, sensitivity analysis, treatment response, unspecified side effect
Citation
Cochrane Database of Systematic Reviews
4
4